Consolo Letteria, Rusconi Daniele, Colombo Stella, Basile Ilaria, Campa Tiziana, Pezzera Daniele, Benenati Salvatore, Caraceni Augusto, Lusignani Maura
Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.
Bachelor School of Nursing, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan Italy.
Am J Hosp Palliat Care. 2025 Feb;42(2):186-196. doi: 10.1177/10499091241240667. Epub 2024 Mar 19.
Electronic patient-reported outcome measures (e-PROMs) offer advantages in palliative cancer care, including rapid completion, improved data quality and direct storage, improving clinical decision-making. The electronic Integrated Palliative Care Outcome Scale (e-IPOS) in this context enables thorough self-assessment by patients, enhancing symptom management and self-reflection of their current situation.
To evaluate the feasibility of implementing the e-IPOS in home palliative cancer care.
The primary outcomes included the enrollment consent rate, study retention rate, e-IPOS completion rate and response completeness, and the number of clinical assessments and interventions performed during home visits. The secondary outcomes were the number of unscheduled visits and patients' perceived quality of life.
A two-group quasiexperimental clinical pilot study. The control group received standard palliative care, the intervention group received standard care along with weekly e-IPOS completion during home visits. Both groups were enrolled for 4 weeks.
SETTING/PARTICIPANTS: Adults with advanced cancer from the home palliative care unit of the Istituto Nazionale dei Tumori of Milan.
Twenty-three patients were enrolled (74.19%), and 20 completed the study (drop-out: 13.04%). 82.5% of the expected e-IPOS responses were received, of which 96.9% were fully complete. In the intervention group, the Wilcoxon test showed an increase in identified needs and documented interventions ( < .05) and a decrease in unscheduled visits ( < .05).
It is feasible to recruit people via home palliative care for an e-IPOS implementation study. Future fully powered studies should investigate the feasibility and assess patients' perceptions of its use to better understand its clinical benefits.
电子患者报告结局测量(e-PROMs)在姑息性癌症护理中具有诸多优势,包括完成速度快、数据质量提高以及直接存储,有助于改善临床决策。在此背景下,电子综合姑息治疗结局量表(e-IPOS)能使患者进行全面的自我评估,加强症状管理并促进其对自身当前状况的自我反思。
评估在家庭姑息性癌症护理中实施e-IPOS的可行性。
主要结局指标包括入组同意率、研究保留率、e-IPOS完成率和回答完整性,以及家访期间进行的临床评估和干预次数。次要结局指标为非计划访视次数和患者感知的生活质量。
两组半实验性临床试点研究。对照组接受标准姑息治疗,干预组在接受标准治疗的同时,在家访期间每周完成一次e-IPOS。两组均纳入研究4周。
研究地点/参与者:来自米兰国家肿瘤研究所家庭姑息治疗科的晚期癌症成人患者。
23名患者入组(74.19%),20名完成研究(退出率:13.04%)。收到了预期e-IPOS回复的82.5%,其中96.9%为完全完整回复。在干预组中,Wilcoxon检验显示已识别需求和记录的干预措施有所增加(P<0.05),非计划访视次数有所减少(P<0.05)。
通过家庭姑息治疗招募人员进行e-IPOS实施研究是可行的。未来样本量充足的研究应调查其可行性,并评估患者对其使用的看法,以更好地了解其临床益处。